Literature DB >> 32199545

Opioid overdose and inpatient care for substance use disorder care in Massachusetts.

Jake R Morgan1, Jianing Wang2, Joshua A Barocas3, Jenifer L Jaeger4, Natalie N Durham5, Hermik Babakhanlou-Chase5, Monica Bharel5, Alexander Y Walley6, Benjamin P Linas7.   

Abstract

BACKGROUND: Inpatient treatment for substance use disorders is a collection of strategies ranging from short term detoxification to longer term residential treatment. How those with opioid use disorder (OUD) navigate this inpatient treatment system after an encounter for detoxification and subsequent risk of opioid-related overdose is not well understood.
METHODS: We used a comprehensive Massachusetts database to characterize the movement of people with OUD through inpatient care from 2013 to 2015, identifying admissions to inpatient detoxification, subsequent inpatient care, and opioid overdose while navigating treatment. We measured the person-years accumulated during each transition period to calculate rates of opioid-related overdose, and investigated how overdose differed in select populations.
RESULTS: Sixty-one percent of inpatient detoxification admissions resulted in a subsequent inpatient detoxification admission without progressing to further inpatient care. Overall, there were 287 fatal and 7337 non-fatal overdoses. Persons exiting treatment after detoxification had the greatest risk of overdose (17.3 per 100 person-years) compared to those who exited after subsequent inpatient care (ranging from 5.9 to 6.6 overdoses per 100 person-years). Non-Hispanic whites were most at risk for opioid related overdose with 16 overdoses per 100 person-years and non-Hispanic blacks had the lowest risk with 5 overdoses per 100 person-years.
CONCLUSIONS: The majority of inpatient detoxification admissions do not progress to further inpatient care. Recurrent inpatient detoxification admission is common, likely signifying relapse. Rather than functioning as the first step to inpatient care, inpatient detoxification might be more effective as a venue for implementing strategies to expand addiction services or treatment such as medications for opioid use disorder.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Opioid use; Overdose; Substance use

Mesh:

Substances:

Year:  2020        PMID: 32199545      PMCID: PMC7928069          DOI: 10.1016/j.jsat.2020.01.017

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  22 in total

1.  The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review.

Authors:  Dominique de Andrade; Rachel A Elphinston; Catherine Quinn; Julaine Allan; Leanne Hides
Journal:  Drug Alcohol Depend       Date:  2019-06-20       Impact factor: 4.492

2.  Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study.

Authors:  Edle Ravndal; Ellen J Amundsen
Journal:  Drug Alcohol Depend       Date:  2010-04-01       Impact factor: 4.492

3.  Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs.

Authors:  Alexander Y Walley; Debbie M Cheng; Emily K Quinn; Elena Blokhina; Natalia Gnatienko; Christine E Chaisson; Evgeny Krupitsky; Philip O Coffin; Jeffrey H Samet
Journal:  Int J Drug Policy       Date:  2016-11-28

4.  Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.

Authors:  Michael D Stein; Bradley J Anderson; Genie L Bailey
Journal:  J Subst Abuse Treat       Date:  2015-07-14

5.  Overdose after detoxification: a prospective study.

Authors:  James D Wines; Richard Saitz; Nicholas J Horton; Christine Lloyd-Travaglini; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

6.  Correlates of Stigma Severity Among Persons Seeking Opioid Detoxification.

Authors:  Nikki Bozinoff; Bradley J Anderson; Genie L Bailey; Michael D Stein
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

7.  A performance measure for continuity of care after detoxification: relationship with outcomes.

Authors:  Margaret T Lee; Constance M Horgan; Deborah W Garnick; Andrea Acevedo; Lee Panas; Grant A Ritter; Robert Dunigan; Hermik Babakhanlou-Chase; Alfred Bidorini; Kevin Campbell; Karin Haberlin; Alice Huber; Dawn Lambert-Wacey; Tracy Leeper; Mark Reynolds
Journal:  J Subst Abuse Treat       Date:  2014-05-02

Review 8.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  Design and impact of bundled payment for detox and follow-up care.

Authors:  Amity E Quinn; Dominic Hodgkin; Jennifer N Perloff; Maureen T Stewart; Mary Brolin; Nancy Lane; Constance M Horgan
Journal:  J Subst Abuse Treat       Date:  2017-09-21

Review 10.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26
View more
  4 in total

1.  Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetration.

Authors:  Stephen Crystal; Molly Nowels; Mark Olfson; Hillary Samples; Arthur Robinson Williams; Peter Treitler
Journal:  J Subst Abuse Treat       Date:  2021-06-24

2.  Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design.

Authors:  Jake R Morgan; Emily K Quinn; Christine E Chaisson; Elizabeth Ciemins; Nikita Stempniewicz; Laura F White; Benjamin P Linas; Alexander Y Walley; Marc R LaRochelle
Journal:  Med Care       Date:  2022-03-01       Impact factor: 3.178

3.  Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis.

Authors:  Alexandra Savinkina; Rajapaksha W M A Madushani; Golnaz Eftekhari Yazdi; Jianing Wang; Joshua A Barocas; Jake R Morgan; Sabrina A Assoumou; Alexander Y Walley; Benjamin P Linas; Sean M Murphy
Journal:  Addiction       Date:  2022-04-12       Impact factor: 7.256

4.  Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting.

Authors:  Jake R Morgan; Joshua A Barocas; Sean M Murphy; Rachel L Epstein; Michael D Stein; Bruce R Schackman; Alexander Y Walley; Benjamin P Linas
Journal:  JAMA Netw Open       Date:  2020-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.